Study reports two-year outcomes of diabetic macular edema treatment
April 9, 2012 in Ophthalmology
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that was previously demonstrated at 12 months was maintained through 24 months, according to a report published Online First by Archives of Ophthalmology.
Modified Early Treatment Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT) has been the mainstay of treatment for clinically significant diabetic macular edema (CSME) for the last three decades. The procedure reduces the risk of moderate visual loss but visual acuity improves (a 15-letter gain at three years) in less than 3 percent of patients so better treatments have been sought, the authors write in their study background.
Ranjan Rajendram, M.D., F.R.C.Ophth., of Moorfields Eye Hospital, London, and colleagues report on the two-year outcomes of the BOLT study, a prospective randomized controlled trial of 80 patients that evaluated intravitreous bevacizumab (injections into the eye) and modified ETDRS MLT in patients with CSME.
At two years, the mean (average) ETDRS best-corrected visual acuity was 64.4 (Snellen visual acuity equivalent: 20/50) in the bevacizumab group and 54.8 (Snellen equivalent 20/80) in the MLT group, a mean gain of 8.6 letters for bevacizumab and a mean loss of 0.5 letters for MLT. The bevacizumab group gained a median of nine ETDRS letters versus 2.5 ETDRS letters for MLT at 24 months compared with baseline. At 24 months, 49 percent of patients gained 10 or more ETDRS letters and 32 percent gained 15 or more letters in the bevacizumab group compared with 7 percent and 4 percent in the MLT group.
"In conclusion, this investigator-initiated single-center study provides evidence for the longer-term use of bevacizumab in the treatment of persistent DME [diabetic macular edema]," the authors note "Visual acuity benefit was maintained through two years with a reduced injection frequency in the second year despite the long duration of DME and multiple MLTs before entering the study. This finding will be reassuring to physicians charged with delivery of this relatively new treatment."
More information: Arch Ophthalmol. Published online April 9, 2012. doi:10.1001/archophthalmol.2012.393
Journal reference:
JAMA Ophthalmology
Provided by
JAMA and Archives Journals
-
Inexpensive drug to stop sight loss shown to be effective
Jun 10, 2010 |
not rated yet |
0
-
Cancer treatment controls macular edema related to diabetes and to cataract surgery
Jul 31, 2009 |
not rated yet |
0
-
Certain new therapies for age-related eye disease do not appear to increase heart risks
Oct 11, 2010 |
not rated yet |
0
-
Researchers find no difference in drugs for macular degeneration
Oct 01, 2010 |
not rated yet |
0
-
Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration
Oct 09, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Solvability of a circuit
2 hours ago
-
Question about perception of colors around light sources
6 hours ago
-
Does a charged particle rotate when traveling through a static Bf?
7 hours ago
-
Find a link between physics and assignment problems
8 hours ago
-
Light as a source of electricity
8 hours ago
-
A question about the energy stored in a capacitor.
9 hours ago
- More from Physics Forums - Classical Physics
More news stories
New study pinpoints biochemical mechanism underlying fibrosis following glaucoma surgery
The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial ...
Ophthalmology
May 17, 2013 |
not rated yet |
0
|
Early screenings key to diagnosing glaucoma
New research is emphasizing the importance of regular screenings for glaucoma, a disease that deteriorates the optic nerve over time and is a leading cause of irreversible blindness worldwide. The onset of glaucoma is associated ...
Ophthalmology
May 17, 2013 |
not rated yet |
0
|
University partners with Sony to find cure for 'lazy eye'
The University of Nottingham and Nottingham University Hospitals NHS Trust, have been working with Sony Computer Entertainment Europe (SCEE) to develop special 3-D glasses and games to help treat children ...
Ophthalmology
May 08, 2013 |
not rated yet |
0
First corneal transplant with pre-loaded donor tissue performed at Mass. Eye and Ear
The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service ...
Ophthalmology
May 07, 2013 |
5 / 5 (1) |
0
Study provides clarity on supplements for protection against blinding eye disease
Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, ...
Ophthalmology
May 06, 2013 |
3 / 5 (2) |
0
|
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...